Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2022

View Archived Issues

Ginisortamab restores gremlin-1-ablated BMP signaling in CRC cell lines

Novel murine model may shed light for future strategies for aggressive glioblastoma

Servier patents new MAT2A inhibitors

Sumitomo Pharma divulges Chk1 inhibitors

Anti-HER2 domain-specific antibody-drug radioconjugates show promise in models of breast cancer

SAGE Therapeutics describes new GABA-A receptor modulators

Merck & Co. identifies new GLCT-1 inhibitors

Tokyo University of Science discloses LXR antagonists

Silo in commercial evaluation license agreement for next-generation liposomes for autoimmune disease

Dual CXCR4/ACKR3 inhibitor in combination with ICT impedes 4T1 tumor growth and metastasis

FDA clears Fusion's IND applications for FPI-2059 and imaging analogue FPI-2058

[89Zr]-Labeled antibody targeting glypican-1 developed as theranostic for pancreatic cancer

First preclinical data on NR2F6 antagonist TES-4207

Molecular signature predicts cancer risk in patients with NAFLD

Voltron initiates preclinical study of vaccine candidate VTX-067 in immune-oncology model

SAN-903 dampens renal fibrosis in mouse model of chronic kidney disease

Evaxion to advance EVX-03 into clinic for NSCLC

Brilacidin inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 variants in vitro

Soligenix reports 100% protection in NHPs with bivalent vaccine against MARV and SUDV

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...